Grifols in a massive sell-off - looking for opportunities The chart is self-explanatory! Price to earnings getting very low, company is solid and should see a bounce sooner or later at major support levels.by HedgeWalker111
Buy $GRFS - NRPicks 22 AprGrifols, S.A. is engaged in the acquisition, manufacture, preparation and sale of therapeutic products, mainly plasma derivatives. The company operates through the bioscientific, hospital, diagnostic, biosupplies and other divisions.Longby NewroadTraderUpdated 1
Buy $GRFS - NRPicks 11 MarGrifols, S.A. engages in the acquisition, manufacture, preparation and sale of therapeutic products, principally plasma derivatives. The company operates through the Bioscience, Hospital, Diagnostics, Bio Supplies and Others segments. Revenue TTM 5.6B Net Income TTM 208M EBITDA TTM 894M EBITDA marLongby NewroadTraderUpdated 0
Predicción GRF 28-12-2021Predicción para GRF en Corto. Recomendada por nuestro algoritmo de IA. El horizonte temporal de la recomendación es 5 días.Shortby stockfinkES1
Are we at the bottom yet?Grifols stock has been heavely punished during 2021. First the pandemic difficulted the plasma collection. We must take into account the stimulus checks and the unemployment benefits from the US goverment wich might have disuaded people from going to the plasma collection centers to get some extraLongby CaptnBNZ0
GRF is set for actionA nice triangle at the end of a long way down. Even though we did not face the ultimate action, the chances are the stage is set for upside. The best case is to see the short-lived break down but the solo break up is valid as well.Longby crazywlstUpdated 1
$GRFS value playLooks like an overall good company, solid financials & healthy balance sheet. Longby Yogigolf2
GRIFOLS: Throw-back becoming a reality?After surpassing Fib 0.5, it looks like the stock is heading towards 0.382 level (21.81). Right now the company is immersed in a share repurchase program since 12/03/2021 and it has already acquired 19.23% of its €125 million valued shares objective. Maybe the company's financial advisers are playinLongby alexinve0
GRIFOLS: Results day coming on Feb 26. Then to the moon?68.2% of GRIFOLS revenues come from the US and Canada. Covid19 cases there seem to be decreasing. The company is delaying more and more its deadline of results for the phase III of the inmunoglobulina antiCovid-19, now until spring 2021. If GRLS results are positive or better than expected (speciallLongby alexinve0